WallStreetZenWallStreetZen

NYSE: GMED
GLOBUS MEDICAL INC Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for GMED

Based on 10 analysts offering 12 month price targets for GLOBUS MEDICAL INC.
Min Forecast
$70.00+6.9%
Avg Forecast
$82.60+26.15%
Max Forecast
$96.00+46.61%

Should I buy or sell GMED stock?

Based on 10 analysts offering ratings for GLOBUS MEDICAL INC.
Strong Buy
Strong Buy
5 analysts 50%
Buy
4 analysts 40%
Hold
1 analysts 10%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

GMED stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Anonymous
Morgan Stanley
HoldMaintains$68.00+3.85%2022-05-12
RBC Capital
Bottom 10%
10
BuyMaintains$73.00+11.48%2022-05-11
Wells Fargo
Top 14%
87
Strong BuyMaintains$70.00+6.90%2022-05-11
Needham
Bottom 6%
6
BuyMaintains$71.00+8.43%2022-05-11
Morgan Stanley
Bottom 16%
16
HoldMaintains$74.00+13.01%2022-02-22
Credit Suisse
Bottom 17%
17
BuyMaintains$91.00+38.97%2022-02-18
Piper Sandler
Bottom 8%
8
Strong BuyUpgrades$88.00+34.39%2022-01-04
Bank of America
Top 2%
99
Strong BuyUpgrades$80.00+22.17%2021-12-13
Canaccord Genuity
Top 14%
87
Strong BuyMaintains$90.00+37.45%2021-08-05
Citigroup
Bottom 40%
40
Strong BuyMaintains$93.00+42.03%2021-08-05

1 of 2

Forecast return on equity

Is GMED forecast to generate an efficient return?
Company
16.41%
Industry
26.86%
Market
30.86%
GMED's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is GMED forecast to generate an efficient return on assets?
Company
14.66%
Industry
14.03%
GMED is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

GMED earnings per share forecast

What is GMED's earnings per share in the next 3 years based on estimates from 6 analysts?
Avg 1 year Forecast
$2.10+50%
Avg 2 year Forecast
$2.40+71.43%
Avg 3 year Forecast
$2.74+95.71%
GMED's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

GMED revenue forecast

What is GMED's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$1.0B+6.84%
Avg 2 year Forecast
$1.1B+17.98%
Avg 3 year Forecast
$1.3B+31.2%
GMED's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

GMED earnings growth forecast

How is GMED forecast to perform vs Medical Devices companies and vs the US market?
Company
24.75%
Industry
24.04%
Market
15.71%
GMED's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
GMED's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
GMED's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

GMED revenue growth forecast

How is GMED forecast to perform vs Medical Devices companies and vs the US market?
Company
9.18%
Industry
5.76%
Market
8.91%
GMED's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
GMED's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

GMED vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
GMED$65.48$82.60+26.15%Strong Buy
SWAV$160.69$199.29+24.02%Buy
PEN$140.05$268.60+91.79%Strong Buy
IART$60.10$73.50+22.30%Hold
INSP$170.14$293.60+72.56%Strong Buy
View Top Medical Device Stocks

GLOBUS MEDICAL Stock Forecast FAQ

Is GLOBUS MEDICAL Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 10 Wall Street analysts covering (NYSE: GMED) stock is to Strong Buy GMED stock.

Out of 10 analysts, 5 (50%) are recommending GMED as a Strong Buy, 4 (40%) are recommending GMED as a Buy, 1 (10%) are recommending GMED as a Hold, 0 (0%) are recommending GMED as a Sell, and 0 (0%) are recommending GMED as a Strong Sell.

What is GMED's earnings growth forecast for 2022-2024?

(NYSE: GMED) GLOBUS MEDICAL's forecast annual earnings growth rate of 24.75% is forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 24.04%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 15.71%.

GLOBUS MEDICAL's earnings in 2022 is $141,946,000.On average, 6 Wall Street analysts forecast GMED's earnings for 2022 to be $213,676,733, with the lowest GMED earnings forecast at $213,676,733, and the highest GMED earnings forecast at $215,711,749. On average, 6 Wall Street analysts forecast GMED's earnings for 2023 to be $244,201,980, with the lowest GMED earnings forecast at $233,009,389, and the highest GMED earnings forecast at $254,377,063.

In 2024, GMED is forecast to generate $278,797,261 in earnings, with the lowest earnings forecast at $278,797,261 and the highest earnings forecast at $278,797,261.

What is GMED's revenue growth forecast for 2022-2024?

(NYSE: GMED) GLOBUS MEDICAL's forecast annual revenue growth rate of 9.18% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 5.76%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 8.91%.

GLOBUS MEDICAL's revenue in 2022 is $961,307,000.On average, 5 Wall Street analysts forecast GMED's revenue for 2022 to be $104,504,609,328, with the lowest GMED revenue forecast at $104,284,420,543, and the highest GMED revenue forecast at $104,742,299,255. On average, 5 Wall Street analysts forecast GMED's revenue for 2023 to be $115,397,035,144, with the lowest GMED revenue forecast at $112,797,912,070, and the highest GMED revenue forecast at $117,159,969,938.

In 2024, GMED is forecast to generate $128,327,122,982 in revenue, with the lowest revenue forecast at $128,327,122,982 and the highest revenue forecast at $128,327,122,982.

What is GMED's forecast return on assets (ROA) for 2022-2025?

(NYSE: GMED) forecast ROA is 14.66%, which is higher than the forecast US Medical Devices industry average of 14.03%.

What is GMED's Price Target?

According to 10 Wall Street analysts that have issued a 1 year GMED price target, the average GMED price target is $82.60, with the highest GMED stock price forecast at $96.00 and the lowest GMED stock price forecast at $70.00.

On average, Wall Street analysts predict that GLOBUS MEDICAL's share price could reach $82.60 by May 11, 2023. The average GLOBUS MEDICAL stock price prediction forecasts a potential upside of 26.15% from the current GMED share price of $65.48.

What is GMED's Earnings Per Share (EPS) forecast for 2022-2024?

(NYSE: GMED) GLOBUS MEDICAL's current Earnings Per Share (EPS) is $1.40. On average, analysts forecast that GMED's EPS will be $2.10 for 2022, with the lowest EPS forecast at $2.10, and the highest EPS forecast at $2.12. On average, analysts forecast that GMED's EPS will be $2.40 for 2023, with the lowest EPS forecast at $2.29, and the highest EPS forecast at $2.50. In 2024, GMED's EPS is forecast to hit $2.74 (min: $2.74, max: $2.74).

What is GMED's forecast return on equity (ROE) for 2022-2025?

(NYSE: GMED) forecast ROE is 16.41%, which is considered weak.
©2022 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatisticsTrending StocksStock Market SectorsStock Market Industries
Analysts
Top Performing Analysts
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.